Wintest
6721
D. Western Therapeutics Institute
4576
Ridge-i
5572
Forside
2330
River Eletec
6666
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | -79.16%6.78B | 386.11%32.54B | -286.54%-11.37B | -112.84%-2.94B | 58.00%22.92B | 484.69%14.5B | -413.12%-3.77B | -92.13%1.2B | 582.97%15.29B | 25.28%-3.17B |
Net profit before non-cash adjustment | -61.82%5.24B | -33.37%13.72B | 129.85%20.59B | 16.44%8.96B | 10.96%7.69B | 5.94%6.93B | 44.24%6.54B | 54.88%4.54B | -10.91%2.93B | 215.13%3.29B |
Total adjustment of non-cash items | -14.33%3.88B | 1.05%4.52B | 64.26%4.48B | -5.71%2.73B | -4.71%2.89B | 21.32%3.03B | 50.69%2.5B | -33.56%1.66B | 10.71%2.5B | 44.98%2.26B |
-Depreciation and amortization | 5.50%3.69B | 9.29%3.49B | 10.17%3.2B | 6.97%2.9B | 14.87%2.71B | 21.58%2.36B | 11.67%1.94B | 3.38%1.74B | 7.72%1.68B | 15.22%1.56B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --144M | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 60.15%-19.76M | 30.09%-49.6M |
-Share of associates | --63M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -97.94%3.39M |
-Disposal profit | -1,208.65%-1.15B | 38.67%104M | -14.77%75M | 54.39%88M | -70.16%57M | 260.38%191M | 123.66%53M | -221.40%-224M | 151.32%184.51M | -1,390.34%-359.55M |
-Net exchange gains and losses | -104.55%-5M | 277.42%110M | -169.66%-62M | 140.09%89M | -147.64%-222M | 2,812.50%466M | 116.84%16M | -124.81%-95M | 623.01%382.86M | --52.95M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 5,579.31%11.53M | --203K |
-Deferred income tax | --149M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other non-cash items | 39.22%1.14B | -35.60%816M | 458.92%1.27B | -202.92%-353M | 2,186.67%343M | -96.93%15M | 414.74%489M | -62.88%95M | -75.55%255.94M | 1,221.63%1.05B |
Changes in working capital | -116.32%-2.33B | 139.21%14.29B | -149.08%-36.44B | -218.66%-14.63B | 171.98%12.33B | 135.37%4.53B | -156.80%-12.82B | -150.60%-4.99B | 213.25%9.86B | -27.41%-8.71B |
-Change in receivables | -36.05%3.44B | 128.25%5.38B | -107.40%-19.06B | -187.50%-9.19B | 291.76%10.5B | 135.00%2.68B | -44.11%-7.66B | -188.37%-5.32B | 206.89%6.02B | -14.73%-5.63B |
-Change in inventory | -92.41%693M | 142.09%9.13B | -190.02%-21.68B | -280.12%-7.48B | 154.76%4.15B | 130.08%1.63B | -273.78%-5.42B | -135.74%-1.45B | 205.37%4.05B | -238.82%-3.85B |
-Change in prepaid assets | -68.37%62M | 21.74%196M | 140.25%161M | -385.71%-400M | --140M | ---- | ---- | ---- | ---- | ---- |
-Change in payables | -189.23%-3.89B | -128.16%-1.35B | 116.73%4.78B | 187.85%2.21B | -1,256.68%-2.51B | -24.39%217M | -83.87%287M | 962.06%1.78B | -126.94%-206.37M | 196.32%765.98M |
-Change in accrued expense | ---- | ---- | ---- | --146M | ---- | ---- | ---- | ---- | ---- | ---- |
-Provision for loans, leases and other losses | 92.59%52M | -61.43%27M | 89.19%70M | -9.76%37M | 10.81%41M | 105.56%37M | 300.00%18M | ---9M | ---- | ---- |
-Changes in other current assets | -397.79%-2.69B | 227.00%903M | -1,612.77%-711M | 840.00%47M | 116.13%5M | 31.11%-31M | -1,225.00%-45M | --4M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -47.56%-1.24B | -34.89%-839M | -61.56%-622M | 49.07%-385M | 19.66%-756M | -36.97%-941M | -23.12%-687M | 10.49%-558M | 2.65%-623.38M | -17.58%-640.33M |
Interest received (cash flow from operating activities) | -33.76%261M | 26.28%394M | 30.00%312M | -35.83%240M | 19.87%374M | 31.09%312M | 4.85%238M | -12.84%227M | 53.94%260.43M | 23.43%169.18M |
Tax refund paid | 48.17%-3.07B | -50.46%-5.93B | -130.97%-3.94B | 25.61%-1.71B | -26.28%-2.29B | -25.00%-1.82B | -14.69%-1.45B | -12.16%-1.27B | -103.64%-1.13B | -138.65%-554.29M |
Other operating cash inflow (outflow) | 6,700.00%66M | 0.00%-1M | -100.37%-1M | 271M | 0 | 0.00%-1M | -1M | 0 | 2,518,500.00%25.18M | -100.00%-1K |
Operating cash flow | -89.30%2.8B | 267.50%26.17B | -245.52%-15.62B | -122.34%-4.52B | 67.86%20.24B | 312.59%12.06B | -1,343.26%-5.67B | -102.84%-393M | 429.82%13.82B | 8.70%-4.19B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -19.61%-4.84B | -19.19%-4.04B | 28.79%-3.39B | 19.61%-4.77B | -79.01%-5.93B | 5.37%-3.31B | -31.44%-3.5B | -39.49%-2.66B | 21.28%-1.91B | -86.23%-2.42B |
Net investment product transactions | 377.40%1.22B | ---438M | --0 | -488.57%-206M | 96.77%-35M | -3,396.77%-1.08B | -125.20%-31M | 11,221.16%123M | -100.28%-1.11M | 2,052.73%399.14M |
Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | 33.88%-80M | -505.00%-121M | 0.00%-20M | 67.38%-20M | -13.95%-61.31M | 79.44%-53.81M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | 21,900.00%220M | -97.50%1M | 21.21%40M | -46.36%33M | -69.95%61.52M | -29.40%204.73M |
Net changes in other investments | 78.57%-21M | -308.33%-98M | -2,300.00%-24M | 99.07%-1M | -137.78%-107M | -1,000.00%-45M | -97.94%5M | 322.04%243M | 18,320.57%57.58M | 43.47%-316K |
Investing cash flow | 20.46%-3.64B | -34.04%-4.58B | 31.28%-3.42B | 16.14%-4.97B | -30.02%-5.93B | -30.10%-4.56B | -53.53%-3.51B | -23.29%-2.28B | 1.22%-1.85B | -44.81%-1.87B |
Financing cash flow | ||||||||||
Net issuance payments of debt | 127.49%5.16B | -195.02%-18.77B | 178.06%19.75B | 171.95%7.1B | -57.46%-9.87B | -156.17%-6.27B | 295.92%11.16B | 126.85%2.82B | -259.22%-10.5B | -3.68%6.59B |
Net common stock issuance | --0 | --0 | --0 | 210.97%172M | 65.09%-155M | -44,300.00%-444M | 0.00%-1M | 22.54%-1M | 39.50%-1.29M | -1,322.67%-2.13M |
Cash dividends paid | -7.71%-2.84B | -51.18%-2.63B | -87.00%-1.74B | 8.28%-931M | -11.42%-1.02B | -37.61%-911M | -45.49%-662M | -9.85%-455M | -66.64%-414.21M | -0.16%-248.56M |
Cash dividends for minorities | 47.54%-32M | -165.22%-61M | 30.30%-23M | 5.71%-33M | 37.50%-35M | -124.00%-56M | -525.00%-25M | -33.33%-4M | 25.00%-3M | ---4M |
Net other fund-raising expenses | 65.84%-69M | -180.56%-202M | 20.88%-72M | -30.00%-91M | 20.45%-70M | 34.33%-88M | 11.26%-134M | -78.32%-151M | -6.73%-84.68M | -31.57%-79.34M |
Financing cash flow | 110.26%2.22B | -220.92%-21.66B | 188.02%17.91B | 155.80%6.22B | -43.49%-11.15B | -175.13%-7.77B | 368.25%10.34B | 120.07%2.21B | -275.75%-11B | -4.24%6.26B |
Net cash flow | ||||||||||
Beginning cash position | 1.88%4.87B | -16.19%4.78B | -37.87%5.7B | 75.00%9.18B | -5.63%5.24B | 36.47%5.56B | -11.42%4.07B | 22.68%4.6B | 10.86%3.75B | 27.11%3.38B |
Current changes in cash | 1,938.67%1.38B | 93.34%-75M | 65.61%-1.13B | -203.41%-3.27B | 1,272.59%3.17B | -123.24%-270M | 348.29%1.16B | -148.22%-468M | 401.17%970.61M | -70.28%193.67M |
Effect of exchange rate changes | -75.00%41M | -18.81%164M | 201.51%202M | 3.86%-199M | -392.86%-207M | -566.67%-42M | 116.07%9M | 53.38%-56M | -169.31%-120.13M | 150.20%173.32M |
Cash adjustments other than cash changes | 0.00%1M | 0.00%1M | 150.00%1M | -100.21%-2M | 97,500.00%974M | -100.32%-1M | 31,500.00%314M | -99,900.00%-1M | ---1K | ---- |
End cash Position | 29.18%6.29B | 1.88%4.87B | -16.19%4.78B | -37.87%5.7B | 75.00%9.18B | -5.63%5.24B | 36.47%5.56B | -11.43%4.07B | 22.70%4.6B | 10.86%3.75B |
Free cash flow | -109.27%-2.05B | 216.09%22.1B | -104.76%-19.04B | -165.05%-9.3B | 64.17%14.29B | 194.60%8.71B | -187.41%-9.2B | -126.92%-3.2B | 267.18%11.9B | -20.62%-7.12B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |